NCT04524845

Brief Summary

Osteoarthritis is a chronic disease affecting millions of people worldwide, and knee is the second most affected site. Knee osteoarthritis is characterized by knee pain, loss of motion, disability, and muscle weakness, all factors contributing to gait alterations, and impacting greatly the patients quality of life. In the absence of curative treatment, pharmacological and non-pharmacological symptomatic treatments are prescribed to maintain this QoL, and therefore delay surgery to more appropriate window of opportunity later in life. The aim of the study was to investigate the acute effects of three braces, using different unloading strategies, on gait kinematic and kinetic parameters, as well as pain in patients with medial knee ostoeoarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 24, 2020

Completed
Last Updated

August 24, 2020

Status Verified

August 1, 2020

Enrollment Period

1.5 years

First QC Date

August 20, 2020

Last Update Submit

August 21, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Knee Adduction Moment

    Main parameter determined from the force platforms: \- Position of the center of gravity By coupling the techniques of kinematic measurement and ground reaction force, we obtain the Moment of Adduction (or KAM) when walking

    Day : 1

  • Knee Adduction Moment

    Main parameter determined from the force platforms: \- Impact force and vertical propulsive force. By coupling the techniques of kinematic measurement and ground reaction force, we obtain the Moment of Adduction (or KAM) when walking

    Day : 1

Secondary Outcomes (6)

  • Perceived pain

    Day: 1

  • Adduction/abduction angles

    Day: 1

  • Impact and propulsive reaction force of the ground

    Day: 1

  • Step length

    Day: 1

  • Walking speed

    Day: 1

  • +1 more secondary outcomes

Study Arms (4)

Rebel Reliever

EXPERIMENTAL

Rebel Reliever (RR) (Thuasne, Levallois Perret, France) with bilateral rigid frames and two hinges. The valgus correction was set by adjusting the medial and lateral frame lengths to a difference of two or three points as dictated by the participant's feeling and comfort. Six straps maintained the brace in place

Device: Rebel Reliever (RR)

Action Reliever

EXPERIMENTAL

Action Reliever (AR) (Thuasne, Levallois Perret, France) made mainly from textile. Upper and lower straps were adjusted to the participant's feeling and comfort.

Device: Action Reliever

Unloader One

ACTIVE COMPARATOR

Unloader One (UO) (Össur, Reykjavik, Iceland), with unilateral frame and one hinge. Upper and lower straps were adjusted to the setting recommended by the fitting instructions and confirmed by the participant's sensation.

Device: Unloading brace

No orthosis

NO INTERVENTION

Control condition without brace

Interventions

Participants underwent one session of gait analysis. The experimental protocol was divided in four conditions, the control condition without brace (NO), and then three conditions with the different braces tested in a randomized order. For each condition, the participant was fitted with the brace by the same experimenter and equipped with 19/20 retro-reflective markers (without/with brace) on the pelvis and the investigated leg for motion analysis. After a short recording in a fixed standing position (static trial), each participant carried out at least three barefoot walking trials of a few meters long at a self-selected pace. The walking trial was validated if a complete gait cycle occurred on the two 90cm x 90 cm force plates recording the ground reaction forces. After each condition, the participant had to assess knee pain.

Unloader One

Rebel Reliever (RR) (Thuasne, Levallois Perret, France)

Rebel Reliever

Action Reliever (AR) (Thuasne, Levallois Perret, France)

Action Reliever

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral medial KOA classified II or III on the Kellgren-Lawrence scale
  • varus misalignment with a joint space of at least two finger breadths
  • pain level equal or higher than 30 mm on a 100 mm visual analog scale
  • informed written consent

You may not qualify if:

  • limited ability to walk
  • normoaxial knee alignment
  • undergoing physiotherapy
  • cognitive disorders or behavioral disorders (opposition, agitation, dementia)
  • arteriopathy of the lower limbs
  • skin disorders contraindicating the wearing of rigid orthotics
  • severe varicosity preventing the regular wearing of unloading brace

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint-Etienne Jean Monnet University

Saint-Etienne, 42270, France

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Thierry Thomas, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized, cross-over, open labelled, monocentric, controlled trial
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2020

First Posted

August 24, 2020

Study Start

February 1, 2018

Primary Completion

July 31, 2019

Study Completion

March 31, 2020

Last Updated

August 24, 2020

Record last verified: 2020-08

Locations